<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Vet Med Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Vet. Med. Sci</journal-id>
      <journal-id journal-id-type="publisher-id">JVMS</journal-id>
      <journal-title-group>
        <journal-title>The Journal of Veterinary Medical Science</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0916-7250</issn>
      <issn pub-type="epub">1347-7439</issn>
      <publisher>
        <publisher-name>The Japanese Society of Veterinary Science</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25716121</article-id>
      <article-id pub-id-type="pmc">4488415</article-id>
      <article-id pub-id-type="publisher-id">14-0682</article-id>
      <article-id pub-id-type="doi">10.1292/jvms.14-0682</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Pathology</subject>
          <subj-group>
            <subject>Note</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Lymphangiosarcoma with bone formation of the auricle in a dog</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>MINESHIGE</surname>
            <given-names>Takayuki</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>SUGAHARA</surname>
            <given-names>Go</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>OHMURO</surname>
            <given-names>Tamio</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>KAMIIE</surname>
            <given-names>Junichi</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>SHIROTA</surname>
            <given-names>Kinji</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref rid="cor1" ref-type="corresp">
            <sup>*</sup>
          </xref>
        </contrib>
        <aff id="aff1"><label>1)</label>Laboratory of Veterinary Pathology, School of Veterinary
Medicine, Azabu University, 1&#x2013;17&#x2013;71 Fuchinobe, Chuo-ku, Sagamihara, Kanagawa 252&#x2013;5201,
Japan</aff>
        <aff id="aff2"><label>2)</label>Ohmuro Veterinary Clinic, 4262&#x2013;2 Oyamamachi, Machida, Tokyo
194&#x2013;0212, Japan</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>*</label>Correspondence to: Shirota, K., Laboratory of Veterinary
Pathology, Azabu University, 1&#x2013;17&#x2013;71 Fuchinobe, Chuo-ku, Sagamihara, Kanagawa 252&#x2013;5201,
Japan. e-mail: <email xlink:href="shirota@azabu-u.ac.jp">shirota@azabu-u.ac.jp</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>12</day>
        <month>2</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2015</year>
      </pub-date>
      <volume>77</volume>
      <issue>6</issue>
      <fpage>739</fpage>
      <lpage>742</lpage>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>12</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>1</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2015 The Japanese Society of Veterinary Science</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>A 12-year-old mixed-breed neutered female dog was referred with cutaneous tumors at the
left auricle. Histologically, the cutaneous tumor located in the dermis comprised numerous
clefts and cavernous channels lined by neoplastic endothelial cells with no erythrocytes.
Bone tissue without direct contact with neoplastic cells was seen in the well-developed
stromal connective tissue. The neoplastic endothelial cells exhibited mild to moderate
atypia. Immunohistochemically, neoplastic cells were positive for vimentin and negative
for cytokeratin and factor VIII-related antigen. Basement membrane around the neoplastic
lumens was positive for laminin in a linear or granular pattern. Ultrastructural
examination revealed discontinuous basement membrane beneath the tumor cells.
Histopathological features of this case were consistent with lymphangiosarcoma, and
stromal ossification was characteristic.</p>
      </abstract>
      <kwd-group>
        <kwd>bone</kwd>
        <kwd>canine</kwd>
        <kwd>tumor pathology</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Lymphangiosarcoma is a rare malignant cutaneous tumor that derives from the lymphatic
endothelium in humans and domestic animals [<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r9" ref-type="bibr">9</xref>, <xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r13" ref-type="bibr">13</xref>]. Only a small number of case reports have described
canine lymphangiosarcoma [<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r4" ref-type="bibr">4</xref>, <xref rid="r9" ref-type="bibr">9</xref>, <xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r14" ref-type="bibr">14</xref>]. In dogs, lymphangiosarcoma tends to
localize in the subcutis along the ventral midline and limbs, with major reported locations of
the inguinal region, cervical region, hind limb and forelimb [<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r4" ref-type="bibr">4</xref>, <xref rid="r9" ref-type="bibr">9</xref>,
<xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r14" ref-type="bibr">14</xref>].</p>
    <p>We recently encountered a unique case of canine lymphangiosarcoma with bone formation in the
auricle. We describe herein the morphological and immunohistochemical findings of a case of
lymphangiosarcoma of the auricle in a dog.</p>
    <p>A 12-year-old mixed-breed neutered female dog developed cutaneous masses at the left auricle.
The dog had a history of bilateral chronic pruritic otitis externa. The largest mass at the
tip of the auricle was found by the dog&#x2019;s owner 1.5 years before resection of the auricle and
had become gradually enlarged since first discovery. The mass in the region of the tip of the
auricle had slowly grown to 28 &#xD7; 25 mm, but no swelling was apparent in surrounding tissues
(<xref ref-type="fig" rid="fig_001">Fig. 1</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig. 1.</label><caption><p>The cutaneous mass (arrows) in the region of the tip of the left auricle. Two
millet-sized daughter nodules (arrowheads) were present on postauricular skin. Bar=50
mm.</p></caption><graphic xlink:href="jvms-77-739-g001"/></fig>). Two millet-sized daughter nodules developed on the postauricular skin during the
period of primary tumor development. Resection of the auricle was performed, and the specimen
was submitted to our laboratory for histopathological examination. The largest mass was soft
on palpation, but difficult to transect due to presence of a calcified lesion within the
center of the mass. Effusion of a clear serous fluid was noted from the cut surface. During
the 14 months since surgical excision, no local recurrence or metastasis has been
recognized.</p>
    <p>The mass was fixed in 10% neutral-buffered formalin, embedded in paraffin, sectioned and
stained with hematoxylin and eosin (HE), alcian blue (pH 2.5), periodic acid-Schiff (PAS) and
Watanabe&#x2019;s silver impregnation. Surface decalcification of paraffin-embedded sections for HE
staining was performed by placing tissue blocks in Plank-Rychlo&#x2019;s solution (0.3 M aluminium
chloride, 3% HCl and 5% formic acid) for 20 min at room temperature. Immunohistochemistry
(IHC) was performed by the immunoenzyme polymer method using the primary antibodies shown in
<xref rid="tbl_001" ref-type="table">Table 1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Primary antibodies and immunostaining protocol in the current study</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" rowspan="1" colspan="1">Antibody<sup>a)</sup></th><th align="center" rowspan="1" colspan="1">Clone</th><th align="center" rowspan="1" colspan="1">Dilution</th><th align="center" rowspan="1" colspan="1">Source</th><th align="center" rowspan="1" colspan="1">Antigen retrieval<sup>b)</sup></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Pan-CK</td><td align="left" rowspan="1" colspan="1">AE1/AE3</td><td align="center" rowspan="1" colspan="1">1:50</td><td align="left" rowspan="1" colspan="1">Dako Denmark A/S., Glostrup, Denmark</td><td align="left" rowspan="1" colspan="1">MW, 95&#xB0;C, 10 min</td></tr><tr><td align="left" rowspan="1" colspan="1">Vimentin</td><td align="left" rowspan="1" colspan="1">SP20</td><td align="center" rowspan="1" colspan="1">1:100</td><td align="left" rowspan="1" colspan="1">Nichirei Corp., Tokyo, Japan</td><td align="left" rowspan="1" colspan="1">MW, 95&#xB0;C, 10 min</td></tr><tr><td align="left" rowspan="1" colspan="1">Factor VIII-related antigen</td><td align="left" rowspan="1" colspan="1">Polyclonal</td><td align="center" rowspan="1" colspan="1">prediluted</td><td align="left" rowspan="1" colspan="1">Dako Denmark A/S., Glostrup, Denmark</td><td align="left" rowspan="1" colspan="1">pepsin, 37&#xB0;C, 20 min</td></tr><tr><td align="left" rowspan="1" colspan="1">SMA</td><td align="left" rowspan="1" colspan="1">1A4</td><td align="center" rowspan="1" colspan="1">1:100</td><td align="left" rowspan="1" colspan="1">Dako Denmark A/S., Glostrup, Denmark</td><td align="left" rowspan="1" colspan="1">No treatment</td></tr><tr><td align="left" rowspan="1" colspan="1">Ki67</td><td align="left" rowspan="1" colspan="1">MIB-1</td><td align="center" rowspan="1" colspan="1">1:100</td><td align="left" rowspan="1" colspan="1">Dako Denmark A/S., Glostrup, Denmark</td><td align="left" rowspan="1" colspan="1">AC, 121&#xB0;C, 20 min</td></tr><tr><td align="left" rowspan="1" colspan="1">Laminin</td><td align="left" rowspan="1" colspan="1">Polyclonal</td><td align="center" rowspan="1" colspan="1">1:100</td><td align="left" rowspan="1" colspan="1">Progen Biotechnik., Heidelberg, Germany</td><td align="left" rowspan="1" colspan="1">pepsin, 37&#xB0;C, 20 min</td></tr></tbody></table><table-wrap-foot><p>a) CK=cytokeratin, b) MW=microwave, citrate buffer (PH6.0); AC=autocleve, citrate
buffer (PH6.0); Pepsin=0.4% pepsin (Sigma-Aldrich Co., St. Louis, MO, U.S.A.).</p></table-wrap-foot></table-wrap>. Peroxidase-conjugated anti-mouse (Histofine Simple Stain MAX-PO (M); Nichirei,
Tokyo, Japan) or anti-rabbit (Histofine Simple Stain MAX-PO (R); Nichirei) immunoglobulin (Ig)
G was used as secondary antibodies. Immunofluorescence testing was performed using
anti-laminin antibody (<xref rid="tbl_001" ref-type="table">Table 1</xref>). After blocking
with 4% Block Ace<sup>TM</sup>(Snow Brand Milk Products, Sapporo, Japan) for 10 min at room
temperature, dewaxed sections were incubated with anti-laminin antibody. After washing with
PBS, sections were stained with Alexa Fluor 488 conjugated anti-rabbit IgG (Invitrogen, Tokyo,
Japan). Fluorescence was analyzed using a FSX100 fluorescence microscope (Olympus, Tokyo,
Japan). In addition, part of the formalin-fixed tissue specimen was cut into 1-mm<sup>3</sup>
cubes, re-fixed in 2.5% glutaraldehyde, post-fixed in 1% osmium acid and embedded in Epon.
Ultra-thin sections were double-stained with uranyl acetate and lead citrate and then examined
using a transmission electron microscope (JEOL 1210; JEOL, Tokyo, Japan) at 80 kV.</p>
    <p>Histologically, the largest infiltrative mass at the tip region was located in the dermis.
The mass comprised numerous irregular lumens or slit-like spaces with no erythrocytes and
lined by plump or spindle-shaped neoplastic cells (<xref ref-type="fig" rid="fig_002">Fig. 2</xref><fig orientation="portrait" fig-type="figure" id="fig_002" position="float"><label>Fig. 2.</label><caption><p>The mass was located in the dermis and comprised numerous clefts and cavernous
channels lined by neoplastic endothelial cells with no erythrocytes.
<italic>Inset</italic>: Mitotic figure in the lining cells (arrowhead). Hematoxylin
and eosin (HE) stain. Bar=300 <italic>&#xB5;</italic>m.</p></caption><graphic xlink:href="jvms-77-739-g002"/></fig>). Neoplastic cells exhibited mild to moderate atypia and pleomorphism,
varying in size. The mitotic activity of neoplastic cells was mild, at 2 mitoses per 10
high-power fields. Localized bone tissue without direct contact with neoplastic cells and
cartilage of the auricle was seen in the stromal connective tissue (<xref ref-type="fig" rid="fig_003">Fig. 3</xref><fig orientation="portrait" fig-type="figure" id="fig_003" position="float"><label>Fig. 3.</label><caption><p>Bone formation (asterisk) in the well-developed stroma separated from neoplastic cells.
HE stain, decalcified tissue. Bar=200 <italic>&#xB5;</italic>m.</p></caption><graphic xlink:href="jvms-77-739-g003"/></fig>). The bone tissue did not show lamellar structure and was irregular in shape,
approximately 6 mm in maximum length. Osteoclast-like giant cells and polyhedral osteoblasts
were frequently found on the surface of the bone tissue. Fibrous stroma around the bone
contained irregular osteoid structures (<xref ref-type="fig" rid="fig_004">Fig. 4</xref><fig orientation="portrait" fig-type="figure" id="fig_004" position="float"><label>Fig. 4.</label><caption><p>Osteoclast-like giant cells (arrows) and osteoblasts were frequently found around the
bone tissue (asterisk). Osteoid formation (arrowhead) occurred near the bone tissue.
<italic>Inset</italic>: Osteoclast-like giant cells. HE stain, decalcified tissue.
Bar=200 <italic>&#xB5;</italic>m.</p></caption><graphic xlink:href="jvms-77-739-g004"/></fig>). Alcian blue staining demonstrated no cartilaginous components in and around the bone
tissue. Marked necrosis and superficial ulceration of the epidermis with infection by
Gram-positive cocci were noted at the tip of the ear. Inflammatory cells, mainly comprising
lymphocytes and plasma cells, were scattered throughout the tumor and adjacent soft tissues.
Histopathologically, daughter nodules exhibited similar features to the largest mass, but
without formation of bone tissue.</p>
    <p>Silver staining demonstrated that most neoplastic cells proliferated along reticular fibers.
PAS-stained sections confirmed discrete basement membrane around intratumoral non-neoplastic
capillary vessels, but results were unclear around neoplastic vessels. Basement membrane also
showed staining with anti-laminin antibody. Laminin staining was linear or granular around the
neoplastic lumens or slit-like spaces (<xref ref-type="fig" rid="fig_005">Fig. 5</xref><fig orientation="portrait" fig-type="figure" id="fig_005" position="float"><label>Fig. 5.</label><caption><p>Immunofluorescence (IF) for laminin. Green color indicated positive staining for
laminin. Nuclei were colored blue with 4,6-diamino-2-phenylindole. (a) Laminin
expression was linear or granular around neoplastic vascular channels (arrowheads). The
wall of non-neoplastic vessel showed intense positive staining for laminin (arrows).
Bar=50 <italic>&#xB5;</italic>m. (b) High magnification view of IF for laminin. Laminin
expression was granular around neoplastic vascular channels. Bar=30
<italic>&#xB5;</italic>m.</p></caption><graphic xlink:href="jvms-77-739-g005"/></fig>).</p>
    <p>Neoplastic cells showed diffuse expression of vimentin, but no positive labeling for
cytokeratin (CK) AE1/AE3. Factor VIII-related antigen was intensely positive in normal
endothelial cells of both blood and lymphatic vessels, but neoplastic cells showed no labeling
for factor VIII-related antigen. Smooth muscle actin-positive pericyte layers were not seen in
the structures of any lumens or slit-like spaces. The proliferation rate, evaluated as the
percentage of Ki67-positive cells in 5 high-power fields (including approximately 1,000
cells), was 10.7%.</p>
    <p>Ultrastructural examination revealed empty clefts devoid of blood cells and lined by
neoplastic cells with oval nuclei and a paranuclear zone rich in intermediate filaments. There
were no pericytes around the neoplastic vasculatures. Weibel-palade bodies were not found in
the neoplastic cells examined. Basement membrane was apparent, but partly unclear beneath the
tumor cells, of which findings might be consistent with those in immunofluorescence for
laminin (<xref ref-type="fig" rid="fig_006">Fig. 6</xref><fig orientation="portrait" fig-type="figure" id="fig_006" position="float"><label>Fig. 6.</label><caption><p>Ultrastructural examination revealed empty clefts (asterisk) devoid of blood cells,
lined by neoplastic cells with oval nuclei and a paranuclear zone rich in intermediate
filaments (white arrows). Basement membrane beneath the neoplastic cells was detected
(black arrows), but it was partly unclear (arrowheads). Weibel-palade bodies were not
present in the neoplastic cells. Bar=2 <italic>&#xB5;</italic>m.</p></caption><graphic xlink:href="jvms-77-739-g006"/></fig>).</p>
    <p>The differential diagnosis of hemangiosarcoma and lymphangiosarcoma is based on both
immunohistochemical and morphological features. Recently, Halsey <italic>et al.</italic>[<xref rid="r4" ref-type="bibr">4</xref>] have shown usability of novel lymphatic endothelial cells
markers; lymphatic vessel endothelial receptor-1 (LYVE-1) and prospero-related homeobox-gene-1 (PROX-1) for differential diagnosis of vascular tumors in dogs. However, in the
present case, a lack or greatly reduced presence of erythrocytes, lymphoplasmacytic
infiltration in the tumor, absence of pericytes and lack of Weibel-palade bodies in the
neoplastic cells suggest the tumor to be a lymphangiosarcoma, not a hemangiosarcoma [<xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r15" ref-type="bibr">15</xref>]. Moreover,
unclear or discontinuous basement membrane as seen by electron microscopy or PAS staining in
the present case was consistent with previous descriptions of lymphangiosarcoma in animals
[<xref rid="r2" ref-type="bibr">2</xref>, <xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r11" ref-type="bibr">11</xref>]. The granular immunoreactivity for laminin around
neoplastic vascular channels might indicate discontinuous basement membrane in agreement with
ultrastructural finding. According to some previous cases, distinguishing well-differentiated
lymphangiosarcoma from lymphangiomatosis might be difficult. In our case, the presence of
daughter nodules, mitotic activity and markedly infiltrative growth separated
lymphangiomatosis from lymphangiosarcoma.</p>
    <p>This is the first report of canine lymphangiosarcoma which occurred in the auricle. The
trigger for the development of canine lymphangiosarcoma remains unclear in most cases.
However, most lymphangiosarcomas in humans arise against a background of chronic lymphedema
following mastectomy, trauma or irradiation [<xref rid="r13" ref-type="bibr">13</xref>]. In
the present case, the dog had no history of chronic lymphedema at the tumor site. We suspect
that chronic inflammation and trauma associated with pruritic otitis externa might have been
involved in the oncogenesis in this case.</p>
    <p>As stated above, the tumor was diagnosed as a lymphangiosarcoma. However, the case was not
histologically typical, because of the accompanying intratumoral bone tissue. Bone formation
has been reported in other soft tissue tumors, including one case of ossifying epithelioid
hemangioendothelioma in humans [<xref rid="r7" ref-type="bibr">7</xref>]. To the best of our
knowledge, bone formation has not been reported in any previous cases of lymphangiosarcoma in
dogs or humans. In the present case, bone tissue in fibrous stroma separated from neoplastic
cells indicated that stromal mesenchymal cells might differentiate into osteoblasts. The
mechanisms and biological signals involved in extraskeletal bone formation are poorly
understood. Imai <italic>et al.</italic>[<xref rid="r6" ref-type="bibr">6</xref>] reported
that bone morphogenetic proteins 2, 4, 5 and 6 may play important roles in ectopic bone
formation in human colon carcinoma. Analysis focused on these factors might thus provide
valuable information regarding bone formation in the present case.</p>
  </body>
  <back>
    <ack>
      <p>We wish to thank Dr. Yoko Kakinuma and Ms. Yuka Isayama of Azabu
University for their valuable assistance.</p>
    </ack>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Curran</surname><given-names>K. M.</given-names></name><name><surname>Halsey</surname><given-names>C. H.</given-names></name><name><surname>Worley</surname><given-names>D. R.</given-names></name></person-group><year>2014</year>. <article-title>Lymphangiosarcoma in 12 dogs: a case
series (1998&#x2013;2013)</article-title>. <source><italic>Vet. Comp. Oncol.</italic></source>
(in press). doi: <pub-id pub-id-type="doi">10.1111/vco.12087</pub-id><pub-id pub-id-type="pmid">24612140</pub-id></mixed-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <mixed-citation publication-type="book"><person-group><name><surname>Goldschmidt</surname><given-names>M. H.</given-names></name><name><surname>Hendrick</surname><given-names>M. J.</given-names></name></person-group><year>2008</year> Tumor of the skin and soft tissues. pp. 45&#x2013;118.
<italic>In</italic>: Tumors in Domestic Animals, 4th ed. (Meuten, D. J. ed.),
Wiley-Blackwell, Ames.</mixed-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <mixed-citation publication-type="book"><person-group><name><surname>Gross</surname><given-names>T. L.</given-names></name><name><surname>Ihrke</surname><given-names>P. J.</given-names></name><name><surname>Walder</surname><given-names>E. J.</given-names></name><name><surname>Affolter</surname><given-names>V. K.</given-names></name></person-group><year>2005</year> Vascular tumors. pp. 735&#x2013;758. <italic>In</italic>: Skin
Diseases of the Dog and Cat. 2nd ed., Blackwell Publishing, Oxford.</mixed-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Halsey</surname><given-names>C. H.</given-names></name><name><surname>Worley</surname><given-names>D. R.</given-names></name><name><surname>Curran</surname><given-names>K.</given-names></name><name><surname>Charles</surname><given-names>J. B.</given-names></name><name><surname>Ehrhart</surname><given-names>E. J.</given-names></name></person-group><year>2014</year>. <article-title>The use of novel lymphatic endothelial
cell-specific immunohistochemical markers to differentiate cutaneous angiosarcomas in
dogs</article-title>. <source><italic>Vet. Comp. Oncol.</italic></source> (in press). doi: <pub-id pub-id-type="doi">10.1111/vco.12088</pub-id><pub-id pub-id-type="pmid">24593773</pub-id></mixed-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <mixed-citation publication-type="book"><person-group><name><surname>Hendrick</surname><given-names>M. J.</given-names></name><name><surname>Mahaffrey</surname><given-names>E. A.</given-names></name><name><surname>Moore</surname><given-names>F. M.</given-names></name></person-group><year>1998</year>. Histological Classification of Mesenchymal Tumors of
Skin and Soft Tissues of Domestic Animals, 2nd ser., vol. 2. Armed Forces Institute of
Pathology, Washington, D. C.</mixed-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Imai</surname><given-names>N.</given-names></name><name><surname>Iwai</surname><given-names>A.</given-names></name><name><surname>Hatakeyama</surname><given-names>S.</given-names></name><name><surname>Matsuzaki</surname><given-names>K.</given-names></name><name><surname>Kitagawa</surname><given-names>Y.</given-names></name><name><surname>Kato</surname><given-names>S.</given-names></name><name><surname>Hokari</surname><given-names>R.</given-names></name><name><surname>Kawaguchi</surname><given-names>A.</given-names></name><name><surname>Nagao</surname><given-names>S.</given-names></name><name><surname>Miyahara</surname><given-names>T.</given-names></name><name><surname>Itoh</surname><given-names>K.</given-names></name><name><surname>Miura</surname><given-names>S.</given-names></name></person-group><year>2001</year>. <article-title>Expression of bone morphogenetic proteins
in colon carcinoma with heterotopic ossification</article-title>.
<source><italic>Pathol. Int.</italic></source><volume>51</volume>:
<fpage>643</fpage>&#x2013;<lpage>648</lpage>. doi: <pub-id pub-id-type="doi">10.1046/j.1440-1827.2001.01243.x</pub-id><pub-id pub-id-type="pmid">11564221</pub-id></mixed-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Kiryu</surname><given-names>H.</given-names></name><name><surname>Hashimoto</surname><given-names>H.</given-names></name><name><surname>Hori</surname><given-names>Y.</given-names></name></person-group><year>1996</year>. <article-title>Ossifying epithelioid
hemangioendothelioma</article-title>. <source><italic>J. Cutan.
Pathol.</italic></source><volume>23</volume>: <fpage>558</fpage>&#x2013;<lpage>561</lpage>.
doi: <pub-id pub-id-type="doi">10.1111/j.1600-0560.1996.tb01449.x</pub-id><pub-id pub-id-type="pmid">9001987</pub-id></mixed-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Puff</surname><given-names>C.</given-names></name><name><surname>Herder</surname><given-names>V.</given-names></name><name><surname>Philipp</surname><given-names>A.</given-names></name><name><surname>Baumg&#xE4;rtner</surname><given-names>W.</given-names></name></person-group><year>2008</year>. <article-title>Lymphangiosarcoma in the nictitating
membrane of a horse</article-title>. <source><italic>J. Vet. Diagn.
Invest.</italic></source><volume>20</volume>: <fpage>108</fpage>&#x2013;<lpage>110</lpage>.
doi: <pub-id pub-id-type="doi">10.1177/104063870802000124</pub-id><pub-id pub-id-type="pmid">18182523</pub-id></mixed-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Sagartz</surname><given-names>J. E.</given-names></name><name><surname>Lairmore</surname><given-names>M. D.</given-names></name><name><surname>Haines</surname><given-names>D.</given-names></name><name><surname>Sheafor</surname><given-names>S. E.</given-names></name><name><surname>Couto</surname><given-names>C. G.</given-names></name></person-group><year>1996</year>. <article-title>Lymphangiosarcoma in a young
dog</article-title>. <source><italic>Vet. Pathol.</italic></source><volume>33</volume>:
<fpage>353</fpage>&#x2013;<lpage>356</lpage>. doi: <pub-id pub-id-type="doi">10.1177/030098589603300316</pub-id><pub-id pub-id-type="pmid">8740713</pub-id></mixed-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Sanchez</surname><given-names>B.</given-names></name><name><surname>Nieto</surname><given-names>A.</given-names></name><name><surname>de Ruiz Leon</surname><given-names>M. A.</given-names></name><name><surname>Rodr&#xED;guez</surname><given-names>J.</given-names></name><name><surname>Flores</surname><given-names>J.</given-names></name></person-group><year>2002</year>. <article-title>Metastatic lymphangiosarcoma in a
horse</article-title>. <source><italic>Vet.
Pathol.</italic></source><volume>39</volume>: <fpage>266</fpage>&#x2013;<lpage>268</lpage>. doi:
<pub-id pub-id-type="doi">10.1354/vp.39-2-266</pub-id><pub-id pub-id-type="pmid">12009065</pub-id></mixed-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Shiga</surname><given-names>A.</given-names></name><name><surname>Shirota</surname><given-names>K.</given-names></name><name><surname>Une</surname><given-names>Y.</given-names></name><name><surname>Nomura</surname><given-names>Y.</given-names></name></person-group><year>1994</year>. <article-title>Lymphangiosarcoma in a
dog</article-title>. <source><italic>J. Vet. Med.
Sci.</italic></source><volume>56</volume>: <fpage>1199</fpage>&#x2013;<lpage>1202</lpage>. doi:
<pub-id pub-id-type="doi">10.1292/jvms.56.1199</pub-id><pub-id pub-id-type="pmid">7696420</pub-id></mixed-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Sugiyama</surname><given-names>A.</given-names></name><name><surname>Takeuchi</surname><given-names>T.</given-names></name><name><surname>Morita</surname><given-names>T.</given-names></name><name><surname>Okamura</surname><given-names>Y.</given-names></name><name><surname>Minami</surname><given-names>S.</given-names></name><name><surname>Tsuka</surname><given-names>T.</given-names></name><name><surname>Tabuchi</surname><given-names>T.</given-names></name><name><surname>Okamoto</surname><given-names>Y.</given-names></name></person-group><year>2007</year>. <article-title>Lymphangiosarcoma in a
cat</article-title>. <source><italic>J. Comp.
Pathol.</italic></source><volume>137</volume>: <fpage>174</fpage>&#x2013;<lpage>178</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/j.jcpa.2007.06.004</pub-id><pub-id pub-id-type="pmid">17706243</pub-id></mixed-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Szuba</surname><given-names>A.</given-names></name><name><surname>Rockson</surname><given-names>S. G.</given-names></name></person-group><year>1998</year>. <article-title>Lymphedema: classification, diagnosis and
therapy</article-title>. <source><italic>Vasc. Med.</italic></source><volume>3</volume>:
<fpage>145</fpage>&#x2013;<lpage>156</lpage>. doi: <pub-id pub-id-type="doi">10.1177/1358836X9800300209</pub-id><pub-id pub-id-type="pmid">9796078</pub-id></mixed-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Williams</surname><given-names>J. H.</given-names></name></person-group><year>2005</year>. <article-title>Lymphangiosarcoma of dogs: a
review</article-title>. <source><italic>J. S. Afr. Vet.
Assoc.</italic></source><volume>76</volume>: <fpage>127</fpage>&#x2013;<lpage>131</lpage>. doi:
<pub-id pub-id-type="doi">10.4102/jsava.v76i3.413</pub-id><pub-id pub-id-type="pmid">16300179</pub-id></mixed-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Williams</surname><given-names>J. H.</given-names></name><name><surname>Birrell</surname><given-names>J.</given-names></name><name><surname>Van Wilpe</surname><given-names>E.</given-names></name></person-group><year>2005</year>. <article-title>Lymphangiosarcoma in a 3.5-year-old
Bullmastiff bitch with vaginal prolapse, primary lymph node fibrosis and other
congenital defects</article-title>. <source><italic>J. S. Afr. Vet.
Assoc.</italic></source><volume>76</volume>: <fpage>165</fpage>&#x2013;<lpage>171</lpage>. doi:
<pub-id pub-id-type="doi">10.4102/jsava.v76i3.420</pub-id><pub-id pub-id-type="pmid">16300186</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
